Answers are grounded in this paper and cite their sources.
With increasing antibiotics resistance, there is an urgent need for novel infection therapeutics. Since antimicrobial peptides provide opportunities for this, identification and optimization of such peptides have attracted much interest during recent years. Here, a brief overview of antimicrobial peptides is provided, with focus placed on how selected hydrophobic modifications of antimicrobial peptides can be employed to combat also more demanding pathogens, including multi-resistant strains, without conferring unacceptable toxicity.
No takes yet. Share an insight, caveat, or question.
Martin Malmsten (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: